L866-2490 Screening compound: N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-3,4-dihydroquinoxalin-2-yl)propanamide

L866-2490 Screening compound: N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-3,4-dihydroquinoxalin-2-yl)propanamide
L866-2490 Screening compound: N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-3,4-dihydroquinoxalin-2-yl)propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L866-2490
N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-3,4-dihydroquinoxalin-2-yl)propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L866-2490

Molecular Formula

C27H34N4O3 (C27 H34 N4 O3)

Compound Name

N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-3,4-dihydroquinoxalin-2-yl)propanamide

IUPAC name

N-(2-methylpropyl)-3-(3-oxo-4-{[(4-phenylbutan-2-yl)carbamoyl]methyl}-34-dihydroquinoxalin-2-yl)propanamide

SMILES

CC(C)CNC(CCC1=Nc(cccc2)c2N(CC(NC(C)CCc2ccccc2)=O)C1=O)=O

InChI

InChI=1S/C27H34N4O3/c1-19(2)17-28-25(32)16-15-23-27(34)31(24-12-8-7-11-22(24)30-23)18-26(33)29-20(3)13-14-21-9-5-4-6-10-21/h4-12,19-20H,13-18H2,1-3H3,(H,28,32)(H,29,33)/t20-/m0/s1

InChI Key

APYNFCKHDUWKJZ-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27482998

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

462.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.987

Distribution Coefficient, logD

2.987

Water Solubility, LogSw

-3.44

Polar Surface Area

71.738

Acid Dissociation Constant (pKa)

15.12

Base Dissociation Constant (pKb)

1.06

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

40.70

L866-2490 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Eccentric PPI Library (11937 compounds)

Glucocorticoid receptors Library (4806 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with L866-2490 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L866-2490?
Check Price and Availability of L866-2490, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L866-2490 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L866-2490
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L866-2490
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L866-2490 available by request